XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Condensed Consolidated Statements of Operations and Comprehensive Loss    
Revenue $ 3,792 $ 2,196
Operating Expenses    
Direct costs 6,274 2,030
Research and development 11,648 6,661
Marketing and sales 432 795
General and administrative 6,756 4,022
Total operating expenses 25,110 13,508
Operating Loss (21,318) (11,312)
Nonoperating Income    
Interest income 4,835 240
Change in fair value of warrant liabilities (2,662) 710
Interest expense (13) (5)
Total nonoperating income 2,160 945
Pretax Loss (19,158) (10,367)
Income tax benefit   (23)
Net Loss Attributable to Common Stockholders (19,158) (10,344)
Other Comprehensive Income (Loss) 885 (330)
Comprehensive Loss Attributable to Common Stockholders $ (18,273) $ (10,674)
Net loss per share - Basic $ (0.11) $ (0.06)
Net loss per share - Diluted $ (0.11) $ (0.06)
Weighted average shares outstanding - Basic 176,934,261 172,395,717
Weighted average shares outstanding - Diluted 176,934,261 172,395,717